Discover how inhibiting PP2A protein phosphatase can dramatically enhance radiation therapy effectiveness against pancreatic cancer cells by disrupting DNA repair mechanisms.
Sirtex Medical's SIR-Spheres Y-90 resin microspheres receive FDA approval for hepatocellular carcinoma treatment, marking a breakthrough in targeted radiation therapy.
Explore how targeted radionuclide therapy is transforming cancer treatment through precision radiation delivery from within the body.